Language

Influcid — packaging
Packaging may differ

Influcid prices in Yerevan pharmacies

aconitum trit.D3, gelsemium trit.D3, ipecacuanha trit.D3, phosphorus trit.D5, bryonia trit. D2, eupatorium perfoliatum trit.D1 · tablets · 25 mg + 25 mg + 25 mg + 25 mg + 25 mg + 25 mg · over the counter

Alpen Pharma GmbH · Germany

Registration No. 20728/1/1 · valid until 10 Jun 2027

  • Over the counter

Prices at 6 online pharmacies

40 pcs · by pack price · prices from pharmacy websites as of 15 Oct 2026

in stock · out of stock · no mark — the pharmacy does not report stock⁠About these prices

These are prices of the pharmacy chains' online shops, not of a particular branch. The list is sorted by pack price; pharmacies where the medicine is out of stock come last.

“≈ … per unit” is Medaro’s calculation: the pack price divided by the number of units (for liquids and ointments — per 10 ml or 10 g), rounded.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Medaro does not sell medicines and is not paid by pharmacies for their place in the list.

Product record

Trade name
Influcid
Active ingredient (INN)
aconitum trit.D3, gelsemium trit.D3, ipecacuanha trit.D3, phosphorus trit.D5, bryonia trit. D2, eupatorium perfoliatum trit.D1
Registration certificate
No. 20728/1/1,
Dispensing
Over the counter

The register has no link to the official leaflet yet — read the leaflet in the pack.

State Register of Medicines (pharm.am) (opens in a new tab)
Show all detailsHide details
Dosage form
tablets
Strength
25 mg + 25 mg + 25 mg + 25 mg + 25 mg + 25 mg
Marketing authorisation holder
Alpen Pharma GmbH, Steinenfeld 3 Zell am Harmersbach, 77736, Germany
Manufacturer
Dr. Gustav Klein GmbH & Co. KG, Steinenfeld 3, 77736 Zell am Harmersbach- bulk manufacturer, packager, quality control (physicochemical), batch releaser, GBA Pharma GmbH, Ernst-Abbe-Str. 40, Ulm, Baden-Wuerttemberg, 89079, Germany- quality control (microbiological)
Country
Germany

Details from the State Register of Medicines of Armenia as of 31 Aug 2026. No indications, directions for use or dosing regimen here — read the official leaflet.

Spotted an error? Let us know

As a rule, we will send you a confirmation that your message has been received and, once the check is done, its outcome. We need your address only for emails about this message: it is not published on the site and is not added to any mailing list. Privacy policy